Healthcare Realty Trust Incorporated (HR)
(Delayed Data from NYSE)
$17.94 USD
+0.03 (0.17%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $17.93 -0.01 (-0.06%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth A Momentum B VGM
Income Statements
Fiscal Year end for Healthcare Realty Trust Incorporated falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 1,344 | 933 | 767 | 739 | 692 |
Cost Of Goods | 500 | 344 | 237 | 227 | 211 |
Gross Profit | 843 | 589 | 530 | 512 | 481 |
Selling & Adminstrative & Depr. & Amort Expenses | 789 | 612 | 377 | 348 | 334 |
Income After Depreciation & Amortization | 54 | -24 | 153 | 164 | 146 |
Non-Operating Income | -78 | 211 | 39 | -16 | -19 |
Interest Expense | 259 | 147 | 93 | 95 | 97 |
Pretax Income | -282 | 41 | 100 | 54 | 31 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | -4 | 0 | 2 | 1 | 1 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -282 | 41 | 100 | 54 | 31 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -278 | 41 | 98 | 53 | 30 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 797 | 434 | 437 | 447 | 427 |
Depreciation & Amortization (Cash Flow) | 743 | 458 | 283 | 283 | 281 |
Income After Depreciation & Amortization | 54 | -24 | 153 | 164 | 146 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 378.93 | 253.87 | 224.22 | 221.67 | 209.61 |
Diluted EPS Before Non-Recurring Items | -0.74 | 0.15 | 0.44 | 0.24 | 0.25 |
Diluted Net EPS (GAAP) | -0.74 | 0.15 | 0.44 | 0.24 | 0.14 |
Fiscal Year end for Healthcare Realty Trust Incorporated falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 316.32 | 326.81 | 330.44 | 342.26 | 338.14 |
Cost Of Goods | 117.72 | 121.08 | 121.36 | 131.64 | 125.40 |
Gross Profit | 198.60 | 205.73 | 209.08 | 210.62 | 212.75 |
SG&A, R&D, and Dept/Amort Expenses | 187.91 | 193.30 | 196.37 | 204.61 | 183.65 |
Income After SG&A, R&D, and Dept/Amort Expenses | 10.69 | 12.43 | 12.71 | 6.01 | 29.10 |
Non-Operating Income | -94.17 | -266.59 | 8.81 | -8.32 | -47.48 |
Interest Expense | 62.46 | 61.05 | 63.19 | 66.30 | 65.33 |
Pretax Income | -145.94 | -315.22 | -41.68 | -68.60 | -83.73 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | -2.16 | -4.38 | -1.14 | -0.76 | -0.97 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -145.94 | -315.22 | -41.68 | -68.60 | -83.73 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -143.78 | -310.84 | -40.53 | -67.84 | -82.76 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 372.48 | 379.46 | 379.04 | 378.93 | 378.90 |
Diluted EPS Before Non-Recurring Items | -0.39 | -0.82 | -0.11 | -0.18 | -0.22 |
Diluted Net EPS (GAAP) | -0.39 | -0.82 | -0.11 | -0.18 | -0.22 |